A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer

Acta Oncologica

Volumn 49, Issue 7, 2010, Pages 1141-1148

  Rosenschöld, Per Munck Af ^a   Aznar, Marianne C ^a   Nygaard, Ditte E ^a   Persson, Gitte F ^a   Korreman, Stine S ^a,b,c   Engelholm, Svend Aage ^a   Nyström, Hkan ^c,d  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Skandion Clinic   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; LUNG; LUNG NEOPLASMS; MOVEMENT; ORGAN SIZE; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TUMOR BURDEN;

EID: 77956607783     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.500620     Document Type: Article

References (35)

1. WHO (February 2006). "Cancer". Lyon: World Health Organization; 2010.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249
3. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592
4. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): A systematic review. Thorax 2001;56:628-638
5. van Rens MT, de la Riviere AB, Elbers HR, van den Bosch JM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000;117:374-379
6. Belderbos JS, Heemsbergen WD, De JK, Baas P, Lebesque JV. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66: 126-134
7. Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Galmarini DH, Garton GR, et al. Medically inoperable lung carcinoma: The role of radiation therapy. Semin Radiat Oncol 1996;6:98-104.
8. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998;40:149-154
9. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 2005;61: 318-328
10. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006;66:1399-1407
11. Lomax AJ. Charged particle therapy: The physics of interaction. Cancer J 2009;15:285-291
12. Turesson I, Johansson KA, Mattsson S. The potential of proton and light ion beams in radiotherapy. Acta Oncol 2003; 42:107-114
13. Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol 1999;44:185-205.
14. Zurlo A, Lomax A, Hoess A, Bortfeld T, Russo M, Goitein G, et al. The role of proton therapy in the treatment of large irradiation volumes: A comparative planning study of pancreatic and biliary tumors. Int J Radiat Oncol Biol Phys 2000;48: 277-288
15. Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;65:1087-1096
16. Georg D, Hillbrand M, Stock M, Dieckmann K, Potter R. Can protons improve SBRT for lung lesions? Dosimetric considerations. Radiother Oncol 2008;88:368-375
17. Grutters JP, Kessels AG, Pijls-Johannesma M, De RD, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis. Radiother Oncol 2010; 95:32-40.
18. Pijls-Johannesma M, Grutters JP, Lambin P, Ruysscher DD. Particle therapy in lung cancer: Where do we stand? Cancer Treat Rev 2008;34:259-267
19. Widesott L, Amichetti M, Schwarz M. Proton therapy in lung cancer: Clinical outcomes and technical issues. A systematic review. Radiother Oncol 2008;86:154-164
20. van de WS, Kreuger R, Zenklusen S, Hug E, Lomax AJ. Tumour tracking with scanned proton beams: Assessing the accuracy and practicalities. Phys Med Biol 2009;54: 6549-6563
21. Seco J, Robertson D, Trofi mov A, Paganetti H. Breathing interplay effects during proton beam scanning: Simulation and statistical analysis. Phys Med Biol 2009;54: N283-N294.
22. Paganetti H, Jiang H, Trofi mov A. 4D Monte Carlo simulation of proton beam scanning: Modelling of variations in time and space to study the interplay between scanning pattern and time-dependent patient geometry. Phys Med Biol 2005;50:983-990
23. Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008; 53:1043-1056
24. Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, et al. 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys 2007;67:906-914
25. Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, et al. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys 2008;72:1385-1395
26. Engelsman M, Rietzel E, Kooy HM. Four-dimensional proton treatment planning for lung tumors. Int J Radiat Oncol Biol Phys 2006;64:1589-1595
27. Zhao L, Sandison GA, Farr JB, Hsi WC, Li XA. Dosimetric impact of intrafraction motion for compensator-based proton therapy of lung cancer. Phys Med Biol 2008;53: 3343-3364
28. Lawson JD, Schreibmann E, Jani AB, Fox T. Quantitative evaluation of a cone-beam computed tomography-planning computed tomography deformable image registration method for adaptive radiation therapy. J Appl Clin Med Phys 2007;8:96-113.
29. Schreibmann E, Thorndyke B, Li T, Wang J, Xing L. Four-dimensional image registration for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:578-586
30. Mattes D, Haynor DR, Vesselle H, Lewellen TK, Eubank W. PET-CT image registration in the chest using free-form deformations. IEEE Trans Med Imaging 2003;22:120-128
31. Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010;76:S70-S76.
32. Yamashita H, Nakagawa K, Nakamura N, Koyanagi H, Tago M, Igaki H, et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2007;2:1-11.
33. Lambert J, Suchowerska N, McKenzie DR, Jackson M. Intrafractional motion during proton beam scanning. Phys Med Biol 2005;50:4853-4862
34. Falk M, Munck af Rosenschold P, Keall P, Cattell H, Cho BC, Poulsen P, et al. Real-time dynamic MLC tracking for inversely optimized arc radiotherapy. Radiother Oncol 2010;94:218-223
35. Sonke JJ, Belderbos J. Adaptive radiotherapy for lung cancer. Semin Radiat Oncol 2010;20:94-106.